1.Application progress of evidence mapping in nursing field
Liangmeng YU ; Xiaoling YU ; Jiamei LI ; Xiaofen RUAN
Chinese Journal of Nursing 2024;59(8):1021-1024,后插1
This review introduces the definition,content,and implementation steps of evidence mapping.It reviews the application of evidence mapping in the field of nursing,explores its role in enhancing the quality of nursing research,and summarizes the advantages,limitations,and prospects for development of evidence mapping.The goal is to strengthen the understanding of evidence mapping among nursing researchers,stimulate research interest,and promote the application of evidence mapping-based evidence synthesis methods in nursing research in China.
2.A Systematic Characterization of Structural Brain Changes in Schizophrenia.
Wasana EDIRI ARACHCHI ; Yanmin PENG ; Xi ZHANG ; Wen QIN ; Chuanjun ZHUO ; Chunshui YU ; Meng LIANG
Neuroscience Bulletin 2020;36(10):1107-1122
A systematic characterization of the similarities and differences among different methods for detecting structural brain abnormalities in schizophrenia, such as voxel-based morphometry (VBM), tensor-based morphometry (TBM), and projection-based thickness (PBT), is important for understanding the brain pathology in schizophrenia and for developing effective biomarkers for a diagnosis of schizophrenia. However, such studies are still lacking. Here, we performed VBM, TBM, and PBT analyses on T1-weighted brain MR images acquired from 116 patients with schizophrenia and 116 healthy controls. We found that, although all methods detected wide-spread structural changes, different methods captured different information - only 10.35% of the grey matter changes in cortex were detected by all three methods, and VBM only detected 11.36% of the white matter changes detected by TBM. Further, pattern classification between patients and controls revealed that combining different measures improved the classification accuracy (81.9%), indicating that fusion of different structural measures serves as a better neuroimaging marker for the objective diagnosis of schizophrenia.